Health Catalyst Inc. (HCAT)
Health Catalyst Statistics
Share Statistics
Health Catalyst has 70.21M shares outstanding. The number of shares has increased by 18.93% in one year.
Shares Outstanding | 70.21M |
Shares Change (YoY) | 18.93% |
Shares Change (QoQ) | 15.39% |
Owned by Institutions (%) | 85.72% |
Shares Floating | 66.95M |
Failed to Deliver (FTD) Shares | 4 |
FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 2.56M, so 4.21% of the outstanding shares have been sold short.
Short Interest | 2.56M |
Short % of Shares Out | 4.21% |
Short % of Float | 4.38% |
Short Ratio (days to cover) | 4.08 |
Valuation Ratios
The PE ratio is -6.12 and the forward PE ratio is 15.67. Health Catalyst's PEG ratio is 0.14.
PE Ratio | -6.12 |
Forward PE | 15.67 |
PS Ratio | 1.39 |
Forward PS | 0.6 |
PB Ratio | 1.17 |
P/FCF Ratio | 32.88 |
PEG Ratio | 0.14 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Health Catalyst.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.69.
Current Ratio | 1.43 |
Quick Ratio | 1.43 |
Debt / Equity | 0.69 |
Debt / EBITDA | -9.26 |
Debt / FCF | 19.4 |
Interest Coverage | -109.59 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $204.39K |
Profits Per Employee | $-46.33K |
Employee Count | 1,500 |
Asset Turnover | 0.36 |
Inventory Turnover | n/a |
Taxes
Income Tax | 333K |
Effective Tax Rate | -0.48% |
Stock Price Statistics
The stock price has increased by -37.93% in the last 52 weeks. The beta is 1.41, so Health Catalyst's price volatility has been higher than the market average.
Beta | 1.41 |
52-Week Price Change | -37.93% |
50-Day Moving Average | 4.99 |
200-Day Moving Average | 6.81 |
Relative Strength Index (RSI) | 40.62 |
Average Volume (20 Days) | 839.6K |
Income Statement
In the last 12 months, Health Catalyst had revenue of 306.58M and earned -69.5M in profits. Earnings per share was -1.15.
Revenue | 306.58M |
Gross Profit | 140.78M |
Operating Income | -69.81M |
Net Income | -69.5M |
EBITDA | -27.1M |
EBIT | -68.53M |
Earnings Per Share (EPS) | -1.15 |
Balance Sheet
The company has 249.65M in cash and 251.09M in debt, giving a net cash position of -1.44M.
Cash & Cash Equivalents | 249.65M |
Total Debt | 251.09M |
Net Cash | -1.44M |
Retained Earnings | -1.19B |
Total Assets | 858.93M |
Working Capital | 139.8M |
Cash Flow
In the last 12 months, operating cash flow was 14.56M and capital expenditures -1.62M, giving a free cash flow of 12.94M.
Operating Cash Flow | 14.56M |
Capital Expenditures | -1.62M |
Free Cash Flow | 12.94M |
FCF Per Share | 0.22 |
Margins
Gross margin is 45.92%, with operating and profit margins of -22.77% and -22.67%.
Gross Margin | 45.92% |
Operating Margin | -22.77% |
Pretax Margin | -22.56% |
Profit Margin | -22.67% |
EBITDA Margin | -8.84% |
EBIT Margin | -22.77% |
FCF Margin | 4.22% |
Dividends & Yields
HCAT does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for HCAT is $9.5, which is 119.9% higher than the current price. The consensus rating is "Buy".
Price Target | $9.5 |
Price Target Difference | 119.9% |
Analyst Consensus | Buy |
Analyst Count | 11 |
Scores
Altman Z-Score | -1.26 |
Piotroski F-Score | 4 |